This July 3, 2020 photo, shows a sign of the World Health Organization (WHO) at their headquarters in Geneva, amidst the COVID-19 outbreak, caused by the novel coronavirus. (FABRICE COFFRINI / AFP)
The World Health Organization warned on Monday that while COVID-19 vaccines undergoing clinical trials may give people hope of protection from infection, it is also possible that they may not work as desired.
There are now 165 COVID-19 vaccine candidates in development, with five already in phase-three clinical trials, according to a WHO report
There are now 165 COVID-19 vaccine candidates in development, with five already in phase-three clinical trials, according to a WHO report on Friday.
"We all hope to have a number of effective vaccines that can help prevent … infection," WHO Director-General Tedros Adhanom Ghebreyesus told a virtual news conference from Geneva.
"However, there is no silver bullet at the moment and there might never be."
ALSO READ: WHO: Proportion of youth with COVID-19 tripled in 5 months
Tedros noted that the speed for development of COVID-19 vaccines has reached an unprecedented level."And there is hope. It doesn't mean that we will have the vaccine," he said.
He said there are concerns that "we may not have a vaccine that may work, or its protection could be for just a few months, not more", adding that until the clinical trials are finished, people will not know if they have a vaccine that can protect effectively and in the long term.
In the meantime, Tedros asked people to focus on measures that are to hand that can help suppress and control the novel coronavirus, such as testing, isolating and treating patients, tracing and quarantining their contacts, informing and empowering communities and strengthening healthcare systems and national unity and global solidarity.
Anthony Fauci, director of the United States' National Institute of Allergy and Infectious Diseases, told lawmakers at a hearing on Friday that a COVID-19 vaccine could be ready for distribution by the end of the year, and distributed to US citizens in 2021.
'Cautiously optimistic'
"From everything we've seen now, in the animal data, as well as the human data, we feel cautiously optimistic that we will have a vaccine by the end of this year and as we go into 2021," he said.
The European Union and the United Kingdom are also racing to secure possible vaccines for their citizens.
The European Commission announced on Friday that on behalf of EU member states, it has made a reservation for 300 million doses of a vaccine being developed by Sanofi and GSK.
"The European Commission does all in its power to ensure that Europeans have rapid access to a vaccine that is safe and protects them from coronavirus," Commission President Ursula von der Leyen said in a news release.
READ MORE: WHO chief: There might be no 'silver bullet' for COVID-19
The UK has signed a deal with GSK and Sanofi for 60 million doses of a potential COVID-19 vaccine. It is the fourth deal of this kind the government has signed in recent months, for a total of 250 million doses so far, the BBC reported.
Russia's Health Minister Mikhail Murashko said on Saturday that the country will start a mass vaccination campaign against COVID-19 from October.
The vaccination will be free of charge and doctors and teachers would be the first to be vaccinated, Turkey's Anadolu Agency reported.
